Literature DB >> 26202065

pH-Dependent Solubility and Dissolution Behavior of Carvedilol--Case Example of a Weakly Basic BCS Class II Drug.

Rania Hamed1, Areeg Awadallah2, Suhair Sunoqrot2, Ola Tarawneh2, Sami Nazzal3, Tamadur AlBaraghthi2, Jihan Al Sayyad2, Aiman Abbas4.   

Abstract

The objective of this study was to investigate the pH-dependent solubility and dissolution of weakly basic Biopharmaceutical Classification Systems (BCS) class II drugs, characterized by low solubility and high permeability, using carvedilol, a weak base with a pK a value of 7.8, as a model drug. A series of solubility and in vitro dissolution studies was carried out using media that simulate the gastric and intestinal fluids and cover the physiological pH range of the GI from 1.2 to 7.8. The effect of ionic strength, buffer capacity, and buffer species of the dissolution media on the solubility and dissolution behavior of carvedilol was also investigated. The study revealed that carvedilol exhibited a typical weak base pH-dependent solubility profile with a high solubility at low pH (545.1-2591.4 μg/mL within the pH range 1.2-5.0) and low solubility at high pH (5.8-51.9 μg/mL within the pH range 6.5-7.8). The dissolution behavior of carvedilol was consistent with the solubility results, where carvedilol release was complete (95.8-98.2% released within 60 min) in media simulating the gastric fluid (pH 1.2-5.0) and relatively low (15.9-86.2% released within 240 min) in media simulating the intestinal fluid (pH 6.5-7.8). It was found that the buffer species of the dissolution media may influence the solubility and consequently the percentage of carvedilol released by forming carvedilol salts of varying solubilities. Carvedilol solubility and dissolution decreased with increasing ionic strength, while lowering the buffer capacity resulted in a decrease in carvedilol solubility and dissolution rate.

Entities:  

Keywords:  buffer species; carvedilol; dissolution; ionic strength; solubility

Mesh:

Substances:

Year:  2015        PMID: 26202065      PMCID: PMC4984888          DOI: 10.1208/s12249-015-0365-2

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  36 in total

1.  Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine.

Authors:  Edmund S Kostewicz; Martin Wunderlich; Ulrich Brauns; Robert Becker; Thomas Bock; Jennifer B Dressman
Journal:  J Pharm Pharmacol       Date:  2004-01       Impact factor: 3.765

2.  Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.

Authors:  Christian Wagner; Ekarat Jantratid; Filippos Kesisoglou; Maria Vertzoni; Christos Reppas; Jennifer B Dressman
Journal:  Eur J Pharm Biopharm       Date:  2012-05-28       Impact factor: 5.571

3.  Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds.

Authors:  Maria Vertzoni; Jennifer Dressman; James Butler; John Hempenstall; Christos Reppas
Journal:  Eur J Pharm Biopharm       Date:  2005-08       Impact factor: 5.571

4.  Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid.

Authors:  Krisztina Takács-Novák; Vera Szőke; Gergely Völgyi; Péter Horváth; Rita Ambrus; Piroska Szabó-Révész
Journal:  J Pharm Biomed Anal       Date:  2013-05-18       Impact factor: 3.935

5.  Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.

Authors:  Lida Kalantzi; Konstantinos Goumas; Vasilios Kalioras; Bertil Abrahamsson; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-12-01       Impact factor: 4.200

6.  Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.

Authors:  Marcel Arndt; Hitesh Chokshi; Kin Tang; Neil J Parrott; Christos Reppas; Jennifer B Dressman
Journal:  Eur J Pharm Biopharm       Date:  2013-02-19       Impact factor: 5.571

7.  The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.

Authors:  Yasuhiro Tsume; Deanna M Mudie; Peter Langguth; Greg E Amidon; Gordon L Amidon
Journal:  Eur J Pharm Sci       Date:  2014-01-28       Impact factor: 4.384

8.  Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.

Authors:  Yanzhuo Zhang; Zhizhuang Zhi; Xue Li; Jian Gao; Yaling Song
Journal:  Int J Pharm       Date:  2013-07-12       Impact factor: 5.875

9.  Toward an improved understanding of the precipitation behavior of weakly basic drugs from oral lipid-based formulations.

Authors:  Cordula Stillhart; Désirée Dürr; Martin Kuentz
Journal:  J Pharm Sci       Date:  2014-02-11       Impact factor: 3.534

10.  Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-beta-cyclodextrin.

Authors:  Sandra Klein; Michael F Wempe; Thomas Zoeller; Norma L Buchanan; Juanelle L Lambert; Michael G Ramsey; Kevin J Edgar; Charles M Buchanan
Journal:  J Pharm Pharmacol       Date:  2009-01       Impact factor: 3.765

View more
  17 in total

1.  Determination and Comparison of the Solubility, Oil-Water Partition Coefficient, Intestinal Absorption, and Biliary Excretion of Carvedilol Enantiomers.

Authors:  Qi Zhang; Xin Wang; Hongjiao Xue; Baolin Huang; Zimin Lin; Zheng Cai
Journal:  AAPS PharmSciTech       Date:  2021-01-10       Impact factor: 3.246

2.  Exploratory Study on Lercanidipine Hydrochloride Polymorphism: pH-Dependent Solubility Behavior and Simulation of its Impact on Pharmacokinetics.

Authors:  Ilia Alekseevich Repin; Raimar Loebenberg; John DiBella; António C L Conceição; Manuel E Minas da Piedade; Humberto G Ferraz; Michele G Issa; Nadia A Bou-Chacra; Catharine F M Ermida; Gabriel L B de Araujo
Journal:  AAPS PharmSciTech       Date:  2021-01-21       Impact factor: 3.246

3.  Use of Flory-Huggins Interaction Parameter and Contact Angle Values to Predict the Suitability of the Drug-Polymer System for the Production and Stability of Nanosuspensions.

Authors:  Rakesh K Patel; Sriramakamal Jonnalagadda; Pardeep K Gupta
Journal:  Pharm Res       Date:  2022-05-03       Impact factor: 4.200

4.  pH-Dependent supersaturation from amorphous solid dispersions of weakly basic drugs.

Authors:  Bo Wang; Matthew J Nethercott; Akshay Narula; Michael Hanrahan; Shanming Kuang; Robert M Wenslow; Na Li
Journal:  Pharm Res       Date:  2021-12-10       Impact factor: 4.200

5.  Amalgamation of Solid Dispersion and Melt Adsorption Technique: Improved In Vitro and In Vivo Performance of Ticagrelor Tablets.

Authors:  Mukesh Yadav; Jayant Sarolia; Bhavin Vyas; Manisha Lalan; Shubhada Mangrulkar; Pranav Shah
Journal:  AAPS PharmSciTech       Date:  2021-10-21       Impact factor: 3.246

6.  Quality by Design (QbD)-Based Numerical and Graphical Optimization Technique for the Development of Osmotic Pump Controlled-Release Metoclopramide HCl Tablets.

Authors:  Sadaf Farooqi; Rabia Ismail Yousuf; Muhammad Harris Shoaib; Kamran Ahmed; Sabah Ansar; Tazeen Husain
Journal:  Drug Des Devel Ther       Date:  2020-11-26       Impact factor: 4.162

7.  Creation of Hydrochlorothiazide Pharmaceutical Cocrystals Via Hot-Melt Extrusion for Enhanced Solubility and Permeability.

Authors:  Sagar Narala; Dinesh Nyavanandi; Abdullah Alzahrani; Suresh Bandari; Feng Zhang; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2022-01-18       Impact factor: 3.246

8.  A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol.

Authors:  Cuiyan Han; Haitao Huang; Yan Dong; Xiaoyu Sui; Baiyu Jian; Wenquan Zhu
Journal:  Molecules       Date:  2019-05-07       Impact factor: 4.411

9.  Deciphering the Molecular Mechanism of Water Interaction with Gelatin Methacryloyl Hydrogels: Role of Ionic Strength, pH, Drug Loading and Hydrogel Network Characteristics.

Authors:  Margaux Vigata; Christoph Meinert; Nathalie Bock; Bronwin L Dargaville; Dietmar W Hutmacher
Journal:  Biomedicines       Date:  2021-05-19

10.  Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations.

Authors:  Dilawar Khan; Daniel Kirby; Simon Bryson; Maryam Shah; Afzal Rahman Mohammed
Journal:  Pharmaceutics       Date:  2021-06-03       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.